Fealey, M.

methylation tumor promoter carcinoma adenomas mgmt promoter methylation status ss 3 adenomas methylation status patient expression mgmt methylation immunoexpression study mgmt methylation status treatment tissue mgmt immunoexpression temozolomide response cancer promoter methylation probe immunohistochemical correlation immunoreactivity methyltransferase fi ndings mgmt immunoreactivity metastase nding fi nding mgmt promoter hypermethylation sample hypermethylation result neurooncol glioblastoma association kovac adenoma immunohistochemical expression horvath e table mgmt immunostaining report therapy paraf methylated metastatic analysis protein kovacs k mgmt immunohistochemical expression promoter methylation status prognostic metastasi repair method detection subset unmethylated endocrinol immunostaining signi ortiz ld horvath tumor recurrence survival syro lv mechanism scheithauer scheithauer bw tmz therapy tmz treatment subtype 3 clin endocrinol tmz response subtype specimen